Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Acquisitions & Divestments (2016 - 2024)

Historic Change in Acquisitions & Divestments for Myriad Genetics (MYGN) over the last 16 years, with Q3 2024 value amounting to $5.0 million.

  • Myriad Genetics' Change in Acquisitions & Divestments fell 6666.67% to $5.0 million in Q3 2024 from the same period last year, while for Jun 2025 it was $5.0 million, marking a year-over-year decrease of 7560.98%. This contributed to the annual value of $9.0 million for FY2024, which is 9144.49% down from last year.
  • Per Myriad Genetics' latest filing, its Change in Acquisitions & Divestments stood at $5.0 million for Q3 2024, which was down 6666.67% from $2.5 million recorded in Q2 2024.
  • Myriad Genetics' Change in Acquisitions & Divestments' 5-year high stood at $58.1 million during Q1 2023, with a 5-year trough of $1.5 million in Q4 2023.
  • Over the past 5 years, Myriad Genetics' median Change in Acquisitions & Divestments value was $18.6 million (recorded in 2020), while the average stood at $21.7 million.
  • As far as peak fluctuations go, Myriad Genetics' Change in Acquisitions & Divestments soared by 31890.24% in 2020, and later plummeted by 9741.82% in 2024.
  • Myriad Genetics' Change in Acquisitions & Divestments (Quarter) stood at $35.9 million in 2020, then tumbled by 32.31% to $24.3 million in 2021, then skyrocketed by 67.08% to $40.6 million in 2022, then tumbled by 96.31% to $1.5 million in 2023, then skyrocketed by 233.33% to $5.0 million in 2024.
  • Its Change in Acquisitions & Divestments was $5.0 million in Q3 2024, compared to $2.5 million in Q2 2024 and $1.5 million in Q1 2024.